» Articles » PMID: 21541359

Congenital Cytomegalovirus Mortality in the United States, 1990-2006

Overview
Date 2011 May 5
PMID 21541359
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Congenital cytomegalovirus (CMV) infection is the most common intrauterine infection in the United States disproportionately affecting minority races and those of lower socio-economic class. Despite its importance there is little information on the burden of congenital CMV-related mortality in the US. To measure congenital CMV-associated mortality in the US and assess possible racial/ethnic disparities, we reviewed national death certificate data for a 17-year period.

Methods: Congenital CMV-associated deaths from 1990 through 2006 were identified from multiple-cause-coded death records and were combined with US census data to calculate mortality rates.

Results: A total of 777 congenital CMV-associated deaths occurred over the 17-year study period resulting in 56,355 years of age-adjusted years of potential life lost. 71.7% (557) of congenital CMV-associated deaths occurred in infants (age less than 1 year). Age-adjusted mortality rates stratified by race/ethnicity revealed mortality disparities. Age-adjusted rate ratios were calculated for each racial/ethnic group using whites as the reference. Native Americans and African Americans were 2.34 (95% CI, 2.11-2.59) and 1.89 (95% CI, 1.70-2.11) times respectively, more likely to die from congenital CMV than whites. Asians and Hispanics were 0.54 (95% CI, 0.44-0.66) and 0.96 (95% CI, 0.83-1.10) times respectively, less likely to die from congenital CMV than whites.

Conclusions/significance: Congenital CMV infection causes appreciable mortality in the US exacting a particular burden among African Americans and Native Americans. Enhanced surveillance and increased screening are necessary to better understand the epidemiology of congenital CMV infection in addition to acceleration of vaccine development efforts.

Citing Articles

Taming the transplant troll: Exploring racial and ethnic disparities in cytomegalovirus infection among kidney transplant patients.

Cabanilla M, Dauenhauer A, St John B, Hill D, Larson J PLoS One. 2025; 20(1):e0317383.

PMID: 39879165 PMC: 11778782. DOI: 10.1371/journal.pone.0317383.


Lissencephaly and Advanced-Stage Congenital Cytomegalovirus Infection in a Neonate.

Manalac A, Lytle E, Khan L, George K Cureus. 2024; 16(6):e61576.

PMID: 38962590 PMC: 11221500. DOI: 10.7759/cureus.61576.


A Geographically Weighted Cost-effectiveness Analysis of Newborn Cytomegalovirus Screening.

Lantos P, Gantt S, Janko M, Dionne F, Permar S, Fowler K Open Forum Infect Dis. 2024; 11(6):ofae311.

PMID: 38933739 PMC: 11200186. DOI: 10.1093/ofid/ofae311.


Exploring health disparities in congenital CMV (cCMV): a study in a Somali-American community to assess awareness of cCMV and facilitate understanding of universal cCMV screening.

Hussein K, Shanley R, Schleiss M Discov Soc Sci Health. 2024; 4(1).

PMID: 38694881 PMC: 11062319. DOI: 10.1007/s44155-024-00070-8.


Evaluation of a Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR)-Based Microneutralization Assay for Assessing Clinical Human Cytomegalovirus-Neutralizing Antibody Activity.

Yu J, Hasing M, Preiksaitis J, Pang X Microorganisms. 2024; 12(4).

PMID: 38674686 PMC: 11052257. DOI: 10.3390/microorganisms12040742.


References
1.
Sorvillo F, DeGiorgio C, Waterman S . Deaths from cysticercosis, United States. Emerg Infect Dis. 2007; 13(2):230-5. PMC: 2725874. DOI: 10.3201/eid1302.060527. View

2.
Boppana S, Fowler K, Britt W, Stagno S, Pass R . Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999; 104(1 Pt 1):55-60. DOI: 10.1542/peds.104.1.55. View

3.
Fowler K, Pass R . Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J Infect Dis. 1991; 164(2):259-64. DOI: 10.1093/infdis/164.2.259. View

4.
Arvin A, Fast P, Myers M, Plotkin S, Rabinovich R . Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin Infect Dis. 2004; 39(2):233-9. DOI: 10.1086/421999. View

5.
Chandler S, ALEXANDER E, Holmes K . Epidemiology of cytomegaloviral infection in a heterogeneous population of pregnant women. J Infect Dis. 1985; 152(2):249-56. DOI: 10.1093/infdis/152.2.249. View